 |
SiteOne Therapeutics
CEO - John Mulcahy
USA | Funding: $134.2M (+)
Website: https://siteonetherapeutics.com/
SiteOne Therapeutics is a biopharmaceutical company that develops pain therapeutics to treat sensory hyperexcitability disorders.
Website: https://siteonetherapeutics.com/
SiteOne Therapeutics is a biopharmaceutical company that develops pain therapeutics to treat sensory hyperexcitability disorders.
